TMC Life Sciences Berhad reported earnings results for the second quarter and six months ended December 31, 2025. For the second quarter, the company reported sales was MYR 103.5 million compared to MYR 80.43 million a year ago. Net income was MYR 6.56 million compared to net loss of MYR 0.947 million a year ago. Basic earnings per share from continuing operations was MYR 0.0038 compared to basic loss per share from continuing operations of MYR 0.0005 a year ago. Diluted earnings per share from continuing operations was MYR 0.0038 compared to diluted loss per share from continuing operations of MYR 0.0005 a year ago.
For the six months, sales was MYR 203.97 million compared to MYR 162.39 million a year ago. Net income was MYR 10.97 million compared to MYR 1.99 million a year ago. Basic earnings per share from continuing operations was MYR 0.0063 compared to MYR 0.0011 a year ago. Diluted earnings per share from continuing operations was MYR 0.0063 compared to MYR 0.0011 a year ago.